CorEvitas International Adolescent Alopecia Areata Registry
This is an observational study (registry) for adolescents aged 12 to 17 who have been diagnosed with severe alopecia areata (AA), a condition where the immune system attacks hair follicles, causing hair loss. The registry will collect information on how AA affects adolescents, how it's managed with routine care from dermatology providers, and the long-term safety and effectiveness of different treatments. The goal is to better understand the disease, evaluate existing medications, and provide information to help doctors and patients make informed decisions about treatment. You would be part of a group of 1500 participants, and your information would be collected until you turn 18 years old.
- Study design
- This is an observational registry that plans to enroll 1500 participants. It is not testing a specific drug, but rather observing routine care.
- What's involved
- Your visit schedule will be determined by your doctor as part of your routine clinical care. Data will be collected through patient-reported outcomes and clinician-reported outcomes.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be followed until you are 18 years old.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- AA epidemiology, presentation, natural history, management, and outcomesThrough Study completion until the subject is 18 years
The major clinical outcomes include an assessment of the epidemiology of Alopecia Areata; to better understand the presentation, natural history, management and outcomes.